Medicine and Dentistry
Therapeutic Procedure
100%
Patient
100%
Survival
100%
Clinical Stage
100%
Metastatic Carcinoma
100%
Serum
100%
Vasculotropin
100%
Ovarian Cancer
100%
Inpatient
38%
Krukenberg Tumor
38%
Ovarian Tumor
38%
Diagnosis
15%
Tumor Progression
15%
Prognosis
15%
Ascites
15%
Sensitivity and Specificity
7%
Biological Marker
7%
Follow up
7%
Female
7%
Enzyme Linked Immunosorbent Assay
7%
Surgery
7%
Tumor Marker
7%
Blood Donor
7%
Survival Time
7%
INIS
patients
100%
cancer
100%
levels
100%
therapy
100%
tumors
100%
growth factors
100%
metastases
100%
correlations
100%
ovaries
100%
carcinomas
25%
comparative evaluations
12%
ascites
12%
humans
6%
enzymes
6%
specificity
6%
blood
6%
sensitivity
6%
biological markers
6%
data
6%
growth
6%
monitoring
6%
elevation
6%
females
6%
surgery
6%
survival time
6%
Pharmacology, Toxicology and Pharmaceutical Science
Metastasis
100%
Survival
100%
Vasculotropin
100%
Ovary Cancer
100%
Ovary Carcinoma
38%
Ovary Tumor
38%
Tumor Growth
15%
Prognosis
15%
Ascites
15%
Biological Marker
7%
Enzyme-Linked Immunosorbent Assay
7%
Tumor Marker
7%
Survival Time
7%
Keyphrases
Serum VEGF
100%
VEGF Levels
50%
Benign Ovarian Tumor
33%
Ovarian Cancer Patients
16%